Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genotypic Evaluation of Chronic Exudative Macular Degeneration Despite Monthly Anti-Vascular Endothelial Growth Factor (VEGF) Therapy

NCT01310686 is registered in ClinicalTrials.gov with West Coast Retina Medical Group, Inc. as lead sponsor.

NCT NCT01310686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01310686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genotypic Evaluation of Chronic Exudative Macular Degeneration Despite Monthly Anti-Vascular Endothelial Growth Factor (VEGF) Therapy
Lead sponsor
West Coast Retina Medical Group, Inc.
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2011
Completion date
June 30, 2019
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

wet amd